NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-041-1991-1-US-01 TRK FAMILY RECEPTORS AS ASSAY SYSTEM FOR COMPOUNDS AFFECTING THE DIFFERENTIATION OF NEURONS US CIP 07/885,731 Abandoned
NIAID E-168-1989-0-US-02 SENSITIVE DIAGNOSTIC TEST FOR LYME DISEASE US FWC 07/885,077 5279938 Expired PDF
NHLBI E-046-1990-0-US-03 SEPARATION OF RARE EARTH ELEMENTS WITH HIGH-SPEED COUNTERCURRENT CHROMATOGRAPHY. US FWC 07/885,069 5215664 Expired PDF
NCI E-082-1991-0-PCT-02 "Stable End-Point" Microculture Tetrazolium Assay (SE-MTA) PCT PCT PCT/US92/03885 Abandoned
NIDDK E-163-1991-0-JP-04 A METHOD FOR REDUCING THE IMMUNOGENICITY OF ANTIBODY VARIABLE DOMAINS JP National Stage JP9191900 Abandoned
NCI E-038-1992-0-US-01 TEST OF HIV-SPECIFIC T LYMPHOCYTE FUNCTION THAT DETECTS EXPOSURE TO HIV ANTIGENS AND POSSIBLY EARLY HIV INFECTION US CIP 07/882,078 Abandoned
NCI E-054-1992-0-US-01 DEVICE FOR MEASURING INCIDENT LIGHT IN A BODY CAVITY US ORD 07/883,013 Abandoned
NIDDK E-163-1991-0-CA-05 A METHOD FOR REDUCING THE IMMUNOGENICITY OF ANTIBODY VARIABLE DOMAINS CA National Stage 2068593 Expired
NINDS E-123-1989-4-US-01 DYNAMICALLY STABLE ASSOCIATIVE LEARNING NEURAL NETWORK SYSTEM US CIP 07/882,646 Abandoned
NCI E-146-1992-0-US-01 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY US ORD 07/882,223 Abandoned
NIDDK E-163-1991-0-EP-03 A METHOD FOR REDUCING THE IMMUNOGENICITY OF ANTIBODY VARIABLE DOMAINS EP National Stage 92304225.3 Expired
NIDA E-028-1994-0-US-01 INHIBITORS OF NITRIC OXIDE SYNTHASE AND USE THEREOF TO PREVENT GLUTAMATE NEUROTOXICITY US ORD 07/881,900 5266594 Expired PDF
NICHD E-186-1989-0-US-03 D-PROPRANOLOL AS A SELECTIVE ADENOSINE ANTAGONIST US DIV 07/881,933 Abandoned
NCI E-067-1990-0-US-20 Bifunctional DTPA-Type Ligand US DIV 07/881,049 5286850 Expired PDF
NIAID E-220-1989-2-US-01 PRODUCTION OF ISOLATED PROTEINACEOUS MATERIALS USING RECOMBINANT AVIPOX VIRUS VECTORS US CIP 07/882,768 Abandoned
NIMH E-011-1989-3-BE-03 Compositions For The Treatment of Chronic Fatigue Syndrome BE EP 92912694.4 Expired
NIMH E-011-1989-3-DK-14 Compositions For The Treatment of Chronic Fatigue Syndrome DK EP 92912694.4 Expired
NIMH E-011-1989-3-NL-05 Compositions For The Treatment of Chronic Fatigue Syndrome NL EP 92912694.2 Expired
NIMH E-011-1989-3-LU-16 Compositions For The Treatment of Chronic Fatigue Syndrome LU EP 92912694.4 Expired
NIMH E-011-1989-3-GR-15 Compositions For The Treatment of Chronic Fatigue Syndrome GR EP 92912694.4 Expired
NIMH E-011-1989-3-DE-06 Compositions For The Treatment of Chronic Fatigue Syndrome DE EP 92912694.4 Expired
NIMH E-011-1989-3-FR-07 Compositions For The Treatment of Chronic Fatigue Syndrome FR EP 92912694.4 Expired
NIMH E-011-1989-3-IT-09 Compositions For The Treatment of Chronic Fatigue Syndrome IT EP 92912694.4 Expired
NIMH E-011-1989-3-GB-08 Compositions For The Treatment of Chronic Fatigue Syndrome GB EP 92912694.4 Expired
NIMH E-011-1989-3-ES-04 Compositions For The Treatment of Chronic Fatigue Syndrome ES EP 92912694.4 Expired
NIMH E-011-1989-3-EP-12 Compositions For The Treatment of Chronic Fatigue Syndrome EP National Stage 92912694.4 Expired
NIMH E-011-1989-3-AU-10 Compositions For The Treatment of Chronic Fatigue Syndrome AU National Stage 20152/92 Expired
NIMH E-011-1989-3-PCT-02 No_Patent_Title PCT PCT PCT/US92/003582 Expired
NINDS E-026-1991-0-PCT-02 No_Patent_Title PCT PCT PCT/US92/003580 Abandoned
NCI E-071-1991-0-PCT-02 Method for Designing Cancer Treatment Regimens and Methods and Pharmaceutical Compositions for the Treatment of Cancer PCT PCT PCT/US92/03830 Expired
NCI E-071-1991-1-US-01 METHOD FOR DESIGNING CANCER TREATMENT REGIMENS AND METHODS AND PHAR- MACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER US CIP 07/880,525 Abandoned
NIDDK E-244-1989-0-US-03 RNA TEMPLATE-SPECIFIC POLYMERASE CHAIN REACTION. US FWC 07/882,253 Abandoned
NIDDK E-104-1989-0-US-09 BIOLOGICALLY ACTIVE SYNTHETIC THYROTROPIN AND CLONED GENE FOR PRODUCING SAME US FWC 07/882,231 Abandoned
NIMH E-011-1989-3-JP-13 Compositions For The Treatment of Chronic Fatigue Syndrome JP National Stage 511956/92 Expired
NIAID E-055-1991-0-CA-13 TRANSMISSION-BLOCKING VACCINE AGAINST MALARIA CA National Stage 2102624 Expired
NIAID E-055-1991-0-IT-06 TRANSMISSION-BLOCKING VACCINE AGAINST MALARIA IT EP 92911372.8 Expired
NIAID E-055-1991-0-EP-11 TRANSMISSION-BLOCKING VACCINE AGAINST MALARIA EP National Stage 92911372.8 Expired
NIAID E-055-1991-0-BE-08 TRANSMISSION-BLOCKING VACCINE AGAINST MALARIA BE EP 92911372.8 Expired
NIAID E-055-1991-0-GB-12 TRANSMISSION-BLOCKING VACCINE AGAINST MALARIA GB EP 92911372.8 Expired
NIAID E-055-1991-0-CH-05 TRANSMISSION-BLOCKING VACCINE AGAINST MALARIA CH EP 92911372.8 Expired
NIAID E-055-1991-0-FR-07 TRANSMISSION-BLOCKING VACCINE AGAINST MALARIA FR EP 92911372.8 Expired
NIAID E-055-1991-0-DE-10 TRANSMISSION-BLOCKING VACCINE AGAINST MALARIA DE EP 92911372.8 Expired
NIAID E-055-1991-0-AU-09 TRANSMISSION-BLOCKING VACCINE AGAINST MALARIA AU National Stage 19132/92 Expired
NIDDK E-147-1992-0-US-01 CRYSTAL STRUCTURE OF TGF-BETA-2 US ORD 07/879,358 5322933 Expired PDF
NIAID E-055-1991-0-PCT-04 No_Patent_Title PCT PCT PCT/US92/003579 Expired
NCI E-200-1990-2-AT-07 RECOMBINANT VIRUS EXPRESSING HUMAN CARCINOEMBRYONIC ANTIGEN AND METHODS OF USE THEREOF AT EP 92913153.0 Expired
NCI E-200-1990-2-DE-09 RECOMBINANT VIRUS EXPRESSING HUMAN CARCINOEMBRYONIC ANTIGEN AND METHODS OF USE THEREOF DE EP 92913153.0 Expired
NCI E-200-1990-2-ES-11 RECOMBINANT VIRUS EXPRESSING HUMAN CARCINOEMBRYONIC ANTIGEN AND METHODS OF USE THEREOF ES EP 92913153.0 Expired
NCI E-200-1990-2-SE-17 RECOMBINANT VIRUS EXPRESSING HUMAN CARCINOEMBRYONIC ANTIGEN AND METHODS OF USE THEREOF SE EP 92913153.0 Expired
NCI E-200-1990-2-DK-10 RECOMBINANT VIRUS EXPRESSING HUMAN CARCINOEMBRYONIC ANTIGEN AND METHODS OF USE THEREOF DK EP 92913153.0 Expired